Kitanovska Biljana Gerasimovska, Gerasimovska Vesna, Livrinova Vesna
University Clinic of Nephrology, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
University Clinic of Gynecology and Obstetrics, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
Open Access Maced J Med Sci. 2016 Sep 15;4(3):439-442. doi: 10.3889/oamjms.2016.073. Epub 2016 Jul 2.
Alport syndrome is a genetic disease that progresses to chronic kidney failure, with X-linked, autosomal dominant or autosomal recessive type of inheritance. Women are generally carriers of the mutation and have a milder form of the disease. During pregnancy, they have an increased risk of impaired kidney function and preeclampsia.
A 27-year old woman, gravida 1, para 0, in her 23rd gestational week came to the outpatient unit of the University Clinic of Nephrology for the first time because of slowly progressing proteinuria and Alport syndrome. She was admitted to the gynaecological ward in her 29th gw for proteinuria which increased from 3.8 g/day up to 20 g/day and the serum creatinine increased to 120- 150 micromol/l. She was delivered in the 30th gestational week due to obstetrical indications with a cesarian section and delivered a baby with a birth weight of 880 g. After delivery, proteinuria decreased to 2 g/d within 2 months and an angiotensin-converting enzyme inhibitor (ACEI) was started. Her second pregnancy, after 2 years, had an uneventful course and she delivered a healthy baby weighing 3000 g in the 39th week. Six months after the second delivery, her renal function remained normal and her proteinuria was 2 g/d.
Pre-pregnancy counselling and frequent controls during pregnancy are necessary for women with Alport syndrome, as well as regular monitoring after delivery. Recent reports are more in favour of good pregnancy and nephrological outcomes in women with Alport syndrome when renal disease is not advanced.
奥尔波特综合征是一种会发展为慢性肾衰竭的遗传性疾病,有X连锁、常染色体显性或常染色体隐性遗传类型。女性通常是突变携带者,病情较轻。在怀孕期间,她们肾功能受损和患先兆子痫的风险会增加。
一名27岁女性,孕1产0,孕23周时因蛋白尿进展缓慢及奥尔波特综合征首次前往大学肾病诊所门诊。孕29周时因蛋白尿从3.8克/天增至20克/天且血清肌酐升至120 - 150微摩尔/升,她被收入妇科病房。因产科指征,她在孕30周时行剖宫产分娩,产下一名出生体重880克的婴儿。产后2个月内蛋白尿降至2克/天,并开始使用血管紧张素转换酶抑制剂(ACEI)。2年后她再次怀孕,孕期顺利,在孕39周时产下一名体重3000克的健康婴儿。第二次分娩后6个月,她的肾功能保持正常,蛋白尿为2克/天。
对于患有奥尔波特综合征的女性,孕前咨询和孕期频繁检查以及产后定期监测是必要的。最近的报告更倾向于认为,当肾病未进展时,患有奥尔波特综合征的女性妊娠及肾病结局良好。